Risk for renal damage following open heart surgery research hub

Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ilofotase Alfa in Patients at Risk for Renal Damage Following Open Heart Surgery.

This study is testing a new medicine, Ilofotase alfa, for people having open-heart surgery. It aims to see if the medicine can help protect their kidneys and prevent damage after the operation. Researchers are comparing it to a dummy medicine.